Autoinflammatory Disease during Covid-19

Epidemiological investigation of COVID-19 in autoinflammatory diseases. Protected confidentiality. Do You agree?

Question Title

* 1. Identity

M (male)

F (female)

Question Title

* 2. Age

Question Title

* 3. Date of Covid-19 diagnosis

Date

Data

Question Title

* 4. Autoinflammatory disease

Familial Mediterranean Fever

TRAPS

Cryopyrin-associated periodic syndrome- CAPS

Hyper IgD syndrome - Mevalonate kinase deficiency

Still's disease

Recurrent pericarditis

PFAPA (periodic fever, aphthous stomatitis, adenitis)

Other (specify) for more information visit the web site: http://rita.ern-net.eu//rare-diseases/#aid-tab

Question Title

* 5. Treatment

Colchicine

Anakinra - (Kineret)

Canakinumab - (Ilaris)

Steroids - (prednisone/dexamethasone)

None

Other (specify )

Question Title

* 6. Colchicine dose, mg

0.5

1.5

more than 2 mg (specify)

Question Title

* 7. Symptoms

Fever

Cough

Dyspnea

Loss of taste

Smell loss

Fatigue - Asthenia

Muscle aches - myalgia

Gastrointestinal symptoms (e.g. diarrhea, nausea)

Headache

Other (specify)

Question Title

* 8. Severity

Fever only >37.5 °C

Home isolation with symptomatic treatment

Hospitalization less than 1 month

Hospitalization over 1 month

Hospitalization in the intensive care unit

Mechanical ventilation

Death

Other (specify)

Question Title

* 9. Other diseases

Obesity

Hypertension

Asthma

Chronic bronchitis

Diabetes mellitus

Cardiopathy

Other (specify)